Physician profile
John I Adams
NPI 1528131943
$482.12
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $91.53 · 2024: $23.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $115.04 | 2019-2020 | |
| Alcon Vision LLC | $98.30 | 2019 | |
| Maculogix, INC. | $82.35 | 2019 | |
| Sun Pharmaceutical Industries INC. | $78.29 | 2019-2020 | |
| Biotissue Holdings INC. | $28.71 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $22.15 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.39 | 2019 | |
| Coopervision INC. | $14.88 | 2019 | |
| Aerie Pharmaceuticals, INC. | $12.22 | 2019 | |
| Notal Vision, INC. | $9.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.